ArticleCancer medicine2023

Immune-independent acquired resistance to PD-L1 antibody initiated by PD-L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib.

Yuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.